T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.
Devillier R
Bone Marrow Transplant. 2015 Nov 9;51(2):194-8. doi: 10.1038/bmt.2015.270
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients.
Crocchiolo R
Haematologica. 2015 Jul 23;100(10):e423-7. doi: 10.3324/haematol.2015.129452
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.
Lobetti-Bodoni C
Mech Ageing Dev. 2012 Jun 9;133(7):479-88. doi: 10.1016/j.mad.2012.05.007
The strange case of the lost NRAS mutation in a child with juvenile myelomonocytic leukemia.
De Filippi P
Pediatr Blood Cancer. 2011 Dec 19;59(3):580-2. doi: 10.1002/pbc.23401
The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R
Haematologica. 2008 Aug 25;93(10):1523-34. doi: 10.3324/haematol.12521
Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.
Matteucci P
Haematologica. 91(2):255-7.
The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice.
Carlo-Stella C
Cancer Res. 66(3):1799-808.
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection.
Di Ianni M
Cancer Gene Ther. 7(6):920-6.
Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
Fogli M
Exp Hematol. 28(7):775-83.
Therapy of molecular relapse in acute promyelocytic leukemia.
Lo Coco F
Blood. 94(7):2225-9.